The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Retracted: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
Abstract
Human cancers, including hepatocellular carcinoma (HCC), are characterized by a high degree of drug resistance in chemotherapy. However, the underlying molecular mechanism remains unknown. To the role of interleukin‐6 (IL‐6)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in the regulation of macrophage polarization, M1‐type and M2‐type macrophages were separately induced using lipopolysaccharide and interleukin‐4 (IL‐4), and we found that the IL‐6/STAT3 signaling pathway was inhibited in M1‐type macrophages but activated in M2‐type macrophages. After anti‐IL‐6‐treated macrophages were separately induced by lipopolysaccharide and IL‐4, we found that the inhibition of IL‐6/STAT3 signaling pathway turned macrophages into M1‐type. Co‐culture with M1‐type macrophages reduced HCC cell viability, proliferation, invasion, migration, drug resistance, but increased apoptosis. Co‐culture with M2‐type macrophages yielded reciprocal results. The inhibition of IL‐6/STAT3 signaling pathway mediated by anti‐IL6 was shown to significantly enhance the effects of M1‐type macrophages on HCC cells and rescue HCC cells from co‐culture with M2‐type macrophages. Tumor xenografts of co‐cultured HCC cells were established in nude mice and the results showed that the inhibition of IL‐6/STAT3 signaling pathway mediated by anti‐IL6 was found to reduce tumor formation of HCC cells co‐cultured with M1‐ or M2‐type macrophages and lung metastases. The current study reveals a novel mechanism of IL‐6/STAT3 signaling pathway in the regulation of macrophage polarization, thus contributing to HCC metastasis and drug resistance in chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang, X., Liang, L., Zhang, X.-F., Jia, H.-L., Qin, Y., Zhu, X.-C., Gao, X.-M., Qiao, P., Zheng, Y., Sheng, Y.-Y., et al. (2013) · Hepatology · doi:10.1002/hep.26305 · Cited by 280
Zhang, C., Li, Y., Wu, Y., Wang, L., Wang, X., & Du, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419788 · Cited by 279 · cited 1×
“The activated IL‐6/STAT3 signaling pathway in macrophages plays a key role in chemokine production from macrophages.(38) Specifically, inducing the phenotypic switch to M1 polarization with inhibition of M2 polarization of tumor‐associated macrophages, which facilitates HCC invasion and metastasis as proven by our stu…”
BackgroundAdvanced Age Impairs Macrophage Polarization
Mahbub, S., Deburghgraeve, C. R., & Kovacs, E. J. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0058 · Cited by 222
IL‐6 trans‐signaling is essential for the development of hepatocellular carcinoma in mice
Bergmann, J., Müller, M., Baumann, N., Reichert, M., Heneweer, C., Bolik, J., Lücke, K., Gruber, S., Carambia, A., Boretius, S., et al. (2017) · Hepatology · doi:10.1002/hep.28874 · Cited by 152
da Silva, C. G., Studer, P., Skroch, M., Mahiou, J., Minussi, D. C., Peterson, C. R., Wilson, S. W., Patel, V. I., Ma, A., Csizmadia, E., et al. (2013) · Hepatology · doi:10.1002/hep.26197 · Cited by 77
Cited by
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Xu, J., Lin, H., Wu, G., Zhu, M., & Li, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.760971 · Cited by 228
Signal transducer and activator of transcription 3 signaling in tumor immune evasion
Zhang, L., Kuca, K., You, L., Zhao, Y., Musilek, K., Nepovimova, E., Wu, Q., Wu, W., & Adam, V. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107969 · Cited by 67
Rong, J., Xu, L., Hu, Y., Liu, F., Yu, Y., Guo, H., Ni, X., Huang, Y., Zhao, L., & Wang, Z. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01563-7 · Cited by 48
Chronic hepatitis B infection with concomitant hepatic steatosis: current evidence and opinion
Shi, Y.-W., Yang, R.-X., & Fan, J.-G. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.3971 · Cited by 47
Metadata
- Authors
- Yin, Z., Ma, T., Lin, Y., Lu, X., Zhang, C., Chen, S., & Jian, Z.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2018-07-17
- Volume
- 119
- Issue
- 11
- Pages
- 9419-9432
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2884747526
- Cited by
- 243
- References
- 5
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.